Shots: The approval of the Pediatric Investigational Plan (PIP) is based on PDCO’s positive opinion for Oxabact (Oxalobacter formigenes) to treat pediatric patients with primary hyperoxaluria Oxabact is currently evaluated […]readmore
Tags : Oxabact